Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Elite provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy.

Andrea Fava is a Rheumatologist in Baltimore, Maryland. Dr. Fava is rated as an Elite provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc).

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE).

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Advanced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. Meredith Atkinson is an associate professor of pediatrics in the Johns Hopkins University School of Medicine. She provides care for children with kidney problems of any type, including patients on dialysis; patients with proteinuria, hematuria and chronic kidney disease; and kidney transplant. Dr. Atkinson's clinical research interests focus on chronic kidney disease and end-stage kidney disease in children. Her specific interests include mechanisms and treatment of anemia in chronic kidney disease and racial disparities in patient outcomes. She is the recipient of numerous research grants and awards, including a K23 Patient Oriented Research award from the National Institute of Diabetes and Digestive and Kidney Diseases/NIH, and young investigator grants from the National Kidney Foundation, the National Kidney Foundation of Maryland, the Thrasher Research Fund and Amgen Inc. She is currently the PI of the Renal Anhydramnios Fetal Therapy (RAFT) trial. She received her undergraduate degree in biology from Mount Holyoke College. She earned her M.D. from the University of Rochester School of Medicine and Dentistry. She completed a residency in pediatrics at Johns Hopkins, followed by a fellowship in pediatric nephrology at Hopkins, completed in June 2007. During her fellowship training, Dr. Atkinson received a master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Atkinson joined the Johns Hopkins faculty in 2007. Dr. Atkinson was elected to the Society for Pediatric Research in 2014. She is a member of several professional organizations including the American Society of Nephrology, and is the president of the American Society of Pediatric Nephrology for 2024-2026. Dr. Atkinson is rated as an Advanced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Potter Syndrome, Lupus Nephritis, Glomerulonephritis, Anemia, and Kidney Transplant.

Dr. Maximilian Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Director of the Cellular Therapy Program (Autoimmunity) in the Department of Medicine at the Johns Hopkins University School of Medicine. He received his medical degree from Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin (Germany) and completed his residency training in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded subspecialty training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital. His clinical interests lie in treating patients with systemic autoimmune diseases, including myositis, scleroderma, lupus, vasculitis, and inflammatory arthritis. Dr. Konig is rated as an Advanced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), and Periodontitis.

Jun Kang is a Dermatologist in Baltimore, Maryland. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Localized Scleroderma.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Daniel Synkowski is a Dermatologist in Baltimore, Maryland. Dr. Synkowski is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Hidradenitis Suppurativa, Melanoma, Actinic Keratosis, and Warts.

Robert Smith is a Pediatrics specialist and a Dermatologist in Baltimore, Maryland. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Hidradenitis Suppurativa, Bullous Pemphigoid, Acne, and Cutaneous Lupus Erythematosus (CLE).

Julia Shalen is a Pediatric Rheumatologist in Baltimore, Maryland. Dr. Shalen is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Systemic Lupus Erythematosus (SLE) and Juvenile Dermatomyositis.

Daniel C. Brennan, M.D., joins the Johns Hopkins Division of Renal Medicine as professor of nephrology and medical director of the Comprehensive Transplant Center. Dr. Brennan’s areas of clinical expertise include transplant nephrology and renal disease. Prior to joining Johns Hopkins, Dr. Brennan was the Alan A. and Edith L. Wolff Professor of renal Diseases at Washington University and the Director of Transplant Nephrology at the Washington University School of Medicine. He received his undergraduate degree from Cornell College and earned his medical degree at the University of Iowa, where he completed a residency in internal medicine. He then completed research and clinical nephrology fellowships at Brigham & Women’s Hospital/Harvard Medical School. Dr. Brennan holds professional memberships at various organizations, including the American College of Physicians, the International Society of Nephrology, the American Society of Nephrology, The Transplantation Society, the American Society of Transplant Physicians and the American Society of Clinical Investigation. Dr. Brennan is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Chronic Kidney Disease, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Kidney Transplant, and Pancreas Transplant.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc).

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy.

George Stojan is a Rheumatologist in Baltimore, Maryland. Dr. Stojan is rated as a Distinguished provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). His top areas of expertise are Systemic Lupus Erythematosus (SLE), Undifferentiated Connective Tissue Disease (UCTD), Lupus Nephritis, and Rheumatoid Arthritis (RA).

Dr. Ana-Maria Orbai is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and psoriatic arthritis. Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Orbai directs the Psoriatic Arthritis Program in the Johns Hopkins Arthritis Center. Her clinical focus is psoriatic arthritis and spodyloarthritis. Dr. Orbai's research aims to understand psoriatic disease subtypes and improve treatment strategies for people with psoriatic arthritis. Dr. Orbai was awarded a Rheumatology Research Foundation Scientist Development award in 2014 and a Jerome L Greene Foundation Scholar award in 2018. Dr. Orbai is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Arthritis, and Rheumatoid Arthritis (RA).

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Scleroderma.

Dr. Geetha is a Professor of Clinical Medicine in the Division of Nephrology, Johns Hopkins University School of Medicine. A graduate of Madras Medical College, India, she completed Internal Medicine training in U.K. She did her Internal Medicine Residency at York, PA and Nephrology fellowship at Johns Hopkins Bayview Medical Center. She has been on Hopkins faculty since 1998. She is the Associate Director of the Johns Hopkins Vasculitis Center and co-director of the Johns Hopkins Glomerular Disease Clinic. She is a member of Royal College of Physicians (U.K.) and Fellow of the American Society of Nephrology. She was inducted to the Miller Coulson Academy of Clinical Excellence. Dr. Geetha is rated as an Experienced provider by MediFind in the treatment of Systemic Lupus Erythematosus (SLE). Her top areas of expertise are Glomerulonephritis, Microscopic Polyangiitis, Chronic Kidney Disease, Granulomatosis with Polyangiitis, and Kidney Transplant.